查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511819

獸用抗生素市場規模、佔有率、趨勢分析報告：按動物類型、劑型、藥物類別、地區和細分市場預測，2024-2030 年

Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Animal Type (Pigs, Cattle), By Dosage Form (Oral Powders, Injections), By Drug Class, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 258 Pages | 商品交期: 2-10個工作天內

價格

獸用抗生素市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計2030年全球獸用抗生素市場規模將達62.9億美元，2024年至2030年複合年成長率為3.10%。

市場成長的主要驅動力包括對專用抗生素和離子載體的日益關注、主要企業不斷增加的舉措和新產品的推出以及牲畜疾病發病率的增加。由於一些較舊的抗生素與抗藥性有關，主要企業正在大力推出新的抗生素來滿足需求。例如，2023年1月，Norbrook推出了Tulieve，這是一種泰拉黴素非專利注射劑，用於治療肉牛、非泌乳乳牛和豬的細菌感染疾病。

同樣，2021年12月，維克推出了用於豬和牛呼吸道疾病的抗生素藥物「Tulicin」。這些產品現已提供給歐洲的獸醫。因此，抗生素開發的研究、開發和製造目前正在進行中，預計這種情況將持續下去，不會很快完全停止。這有助於市場的成長。

未來進一步加速市場成長的機會之一是新抗生素的發現。獸醫仍然需要新的抗生素來對抗新出現的抗藥性菌株。該領域的研究和開發有可能帶來突破性藥物，解決動物感染疾病治療中未滿足的需求。美國農業部表示，創新藥物的開發可以減少抗藥性以及食用動物生產中對現有抗生素的需求。此外，伴同性動物對藥物的需求也可能推動伴同性動物市場而不是食用動物新產品的開發。同時，對美國肉類出口需求的增加加劇了全球化帶來的動物疾病挑戰，而動物抗生素抗藥性的發展可能會推動對抗生素的需求以及新抗生素的開發。

此外，主要獸用抗生素製造商面臨全球學名藥開發商的激烈競爭。這些學名藥因其成本效益也給製造商帶來了價格壓力。當抗生素專利到期時，學名藥開發商將替代配方推向市場。例如，Elanco 的 Maxiban（離子載體/專用抗生素）截至 2021 年沒有專利保護，因此競爭對手可能會開始開發非專利的、成本較低的替代品。同樣，碩騰在 2021 年報告稱，一旦產品專利到期，它將面臨學名藥開發商的競爭。因此，該公司被迫降低價格並為其核心產品提供折扣，以與市場上價格較低的非專利替代品競爭。因此，從長遠來看，日益激烈的非專利競爭預計將對市場構成挑戰。

此外，人們對牲畜疾病的認知不斷提高，預計將增加醫院和診所對獸醫治療的需求，從而導致對獸用抗生素的需求增加。例如，安大略省大約有 5,247 名獸醫，其次是不列顛哥倫比亞省，有 1,650 名獸醫。此外，用於治療牲畜的抗生素必須符合加拿大衛生署的動物安全標準。獸醫可以從多種旨在幫助預防或減輕威脅動物的疾病的嚴重程度的抗生素中進行選擇。所有在該國銷售的抗生素都必須經過加拿大食品檢驗局的批准。這些因素預計將推動市場成長。

獸用抗生素市場報告亮點

  • 依動物類型分類，牛細分市場所佔佔有率最大，2023 年為 39.63%。牛肉和乳製品消費的增加是推動這一領域的主要因素。
  • 依藥品類別分類，2023年四環黴素佔據市場主導地位，佔有率為28.93%。四環黴素是一種常用的獸用抗生素。
  • 口服液體細分市場在2023年佔據市場主導地位，佔有率為50.20%。口服溶液是獸用抗生素最容易開發和使用的劑型。
  • 2023年，北美地區以32.49%的佔有率主導全球市場。該區域市場可能是由於現有參與者的存在以及獸醫診所對治療的需求不斷增加而推動的。
  • 預計亞太地區在預測期內將以 4.10% 的複合年成長率成長最快。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 獸用抗生素市場波動趨勢及範圍

  • 市場體系展望
  • 市場動態
  • 獸用抗生素市場分析工具

第4章獸用抗生素市場：依動物類型估計和趨勢分析

  • 細分儀表板
  • 獸用抗生素市場：以動物類型的波動分析
  • 2018-2030年按動物類型分類的獸用抗生素市場規模與趨勢分析
  • 牛
  • 豬
  • 綿羊和山羊
  • 家禽
  • 其他

第5章獸用抗生素市場：依藥物類別估算與趨勢分析

  • 細分儀表板
  • 獸用抗生素市場：依藥物類別波動分析
  • 2018-2030年獸用抗生素市場規模及趨勢分析（依藥物類別）

第6章獸用抗生素市場：按劑型估算及趨勢分析

  • 細分儀表板
  • 獸用抗生素市場：劑型變化分析
  • 2018-2030年獸用抗生素市場規模及趨勢分析（按劑型）

第7章獸用抗生素市場：依地區估算及趨勢分析

  • 區域儀表板
  • 2023 年及 2030 年獸用抗生素市場佔有率（按地區）
  • 區域展望
  • 北美洲
    • 2018-2030年北美獸用抗生素市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030年歐洲獸用抗生素市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
    • 比利時
    • 匈牙利
    • 波蘭
    • 葡萄牙
    • 羅馬尼亞
    • 荷蘭
  • 亞太地區
    • 2018-2030 年亞太地區獸用抗生素市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 2018-2030年拉丁美洲獸用抗生素市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018-2030 年中東和非洲獸用抗生素市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第8章 競爭格局

  • 市場參與企業分類
  • 企業市場分析/堆圖分析
  • 公司簡介
    • Merck &Co., Inc.
    • Ceva Sante Animale.
    • Vetoquinol
    • Zoetis Services LLC
    • Boehringer Ingelheim International GmbH
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Virbac SA
    • Calier.
    • Bimeda, Inc
    • Prodivet pharmaceuticals SA/NV
    • Norbrook Laboratories
  • 策略規劃
    • 併購
    • 夥伴關係與協作
    • 擴張
    • 產品發表會
    • 產品核可
    • 其他
  • 主要企業名單
Product Code: GVR-4-68040-298-9

Veterinary Antibiotics Market Growth & Trends:

The global veterinary antibiotics market size is expected to reach USD 6.29 billion by 2030, registering a CAGR of 3.10% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary drivers of market growth include a rising focus on animal-only antibiotics and ionophores, growing initiatives by key companies and the launch of new products, and the increasing incidence of livestock diseases. Key players are significantly launching new antibiotics to meet the demand, as some of the older antibiotics have been associated with resistance. For instance, in January 2023, Norbrook launched Tulieve, a generic tulathromycin injection for treating bacterial infections in beef cattle, nonlactating dairy cattle, and swine.

Similarly, in December 2021, Virbac launched Tulissin, an antibiotic solution for swine and cattle with respiratory pathologies. These products were made available for European veterinarians. Therefore, R&D and manufacturing for antibiotic development are ongoing, which is anticipated to continue without a complete halt anytime soon. This factor is contributing to the market growth.

One of the opportunities to further accelerate market growth in the future is the discovery of novel antibiotics. There is a continuous need for new antibiotics to combat emerging resistant strains in veterinary medicine. Research and development in this area could lead to breakthrough drugs that address unmet needs in treating animal infections. According to the U.S. Department of Agriculture, the development of innovative drugs could reduce resistance and the need for existing antibiotics in the production of food animals. Moreover, the need for medications intended for companion animals may promote the development of novel products for that market rather than for use in food animals. On the other hand, increasing export demand for U.S. meat is intensifying animal illness challenges caused by globalization, and the development of antibiotic resistance in animals could boost the demand for antibiotics and the development of new antibiotics.

Moreover, major veterinary antibiotic manufacturers are facing severe competition from generic drug developers globally. These generic products also create pricing pressure on manufacturers owing to their cost-effectiveness. As the patent for antibiotic products expires, generic drug developers introduce alternative forms of products into the market. For instance, Elanco's Maxiban (an ionophore/animal-only antibiotic) has no patent protection as of 2021, thus, competitors might begin to develop generic & lower-priced alternatives. Similarly, Zoetis reported in 2021 that the company faces competition from generic product developers once a product's patent expires. As a result, the company has been compelled to reduce its prices and provide discounts for major products to compete with the lower-priced alternative generic products available in the market. Therefore, increasing generic competition is expected to create challenges in the market in the long run.

In addition, the rising awareness of livestock diseases is predicted to create a demand for veterinary treatment in hospitals & clinics, creating a requirement for veterinary antibiotics. For instance, Ontario has approximately 5,247 veterinarians, followed by 1,650 in British Columbia. Furthermore, antibiotics used for livestock treatment must meet Health Canada's human & animal safety standards. Veterinarians can choose from various antibiotics designed to help prevent or lower the severity of diseases that threaten animals. Every antibiotic marketed in the country must be licensed by the Canadian Food Inspection Agency. Such factors are likely to propel market growth.

Veterinary Antibiotics Market Report Highlights:

  • Based on animal type, the cattle segment held the largest share of 39.63% in 2023. Increased consumption of beef and dairy products is a major factor expected to drive the segment.
  • Based on drug class, the tetracyclines segment dominated the market with a share of 28.93% in 2023. Tetracyclines are a class of commonly used veterinary antibiotics.
  • The oral solutions segment dominated the market with a share of 50.20% in 2023. Oral liquids or solutions are among the easiest dosage forms of veterinary antibiotics to develop and use.
  • North America dominated the global market with a share of 32.49% in 2023. This regional market is likely to be driven by the presence of established players and increasing demand for treatment among veterinary practices.
  • Asia Pacific is anticipated to grow at the fastest CAGR of 4.10% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Antibiotics Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising focus on animal-only antibiotics and ionophores
      • 3.2.1.2. Growing Initiatives by key companies And launch of new products
      • 3.2.1.3. Increasing Incidence of Livestock Diseases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulations
      • 3.2.2.2. Decline In the use of antibiotics
      • 3.2.2.3. Rising research on antibiotic alternatives
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Antibiotics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Patent-Off Dates Analysis for Major Veterinary Antibiotics
    • 3.3.5. Product Pipeline Analysis
    • 3.3.6. Overall Estimated Sales Of Antimicrobial VMPs (Active Substance) In Tonnes By European Country, 2023
    • 3.3.7. Estimated Sales Of Antimicrobial Active Substances in Production Animals in Europe, By Antimicrobial Class, 2023
    • 3.3.8. COVID-19 Impact Analysis

Chapter 4. Veterinary Antibiotics Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Antibiotics Market: Animal type Movement Analysis
  • 4.3. Veterinary Antibiotics Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
  • 4.4. Cattle
    • 4.4.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Pigs
    • 4.5.1. Pigs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Sheep & Goat
    • 4.6.1. Sheep & Goat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Poultry
    • 4.7.1. Poultry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Antibiotics Market: By Drug Class Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Antibiotics Market: By Drug Class Movement Analysis
  • 5.3. Veterinary Antibiotics Market Size & Trend Analysis, by drug class, 2018 to 2030 (USD Million)
    • 5.3.1. Tetracyclines
      • 5.3.1.1. Tetracyclines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Penicillins
      • 5.3.2.1. Penicillins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Sulfonamides
      • 5.3.3.1. Sulfonamides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Penicillins
      • 5.3.4.1. Penicillins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Macrolides
      • 5.3.5.1. Macrolides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.6. Trimethoprim
      • 5.3.6.1. Trimethoprim Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. Lincosamides
      • 5.3.7.1. Lincosamides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.8. Polymyxins
      • 5.3.8.1. Polymyxins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.9. Aminoglycosides
      • 5.3.9.1. Aminoglycosides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.10. Fluoroquinolones
      • 5.3.10.1. Fluoroquinolones Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.11. Pleuromutilins
      • 5.3.11.1. Pleuromutilins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.12. Others
      • 5.3.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Antibiotics Market: By Dosage Form Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Antibiotics Market: By Dosage Form Movement Analysis
  • 6.3. Veterinary Antibiotics Market Size & Trend Analysis, by dosage form, 2018 to 2030 (USD Million)
    • 6.3.1. Oral Powders
      • 6.3.1.1. Oral powders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Oral solutions
      • 6.3.2.1. Oral solutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Injections
      • 6.3.3.1. Injections Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Others
      • 6.3.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Antibiotics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Veterinary Antibiotics Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.3. Regional Outlook
  • 7.4. North America
    • 7.4.1. North America Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. U.S. Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Canada Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. UK Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Germany Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. France Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Italy Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Spain Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Denmark Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Sweden Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Norway Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.10. Belgium
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Belgium Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.11. Hungary
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Hungary Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.12. Poland
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Poland Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.13. Portugal
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Portugal Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.14. Romania
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Romania Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.15. Netherlands
      • 7.5.15.1. Key Country Dynamics
      • 7.5.15.2. Romania Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Japan Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. China Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. India Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Australia Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. South Korea Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Brazil Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Mexico
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Mexico Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. Argentina
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Argentina Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. South Africa Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Saudi Arabia Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. UAE Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis/ Heap Map Analysis
  • 8.3. Company Profiles
    • 8.3.1. Merck & Co., Inc.
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Ceva Sante Animale.
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Vetoquinol
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Zoetis Services LLC
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Boehringer Ingelheim International GmbH
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Dechra Pharmaceuticals PLC
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Elanco Animal Health Incorporated
      • 8.3.7.1. Participant's Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Virbac S.A.
      • 8.3.8.1. Participant's Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Calier.
      • 8.3.9.1. Participant's Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Bimeda, Inc
      • 8.3.10.1. Participant's Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Prodivet pharmaceuticals SA/NV
      • 8.3.11.1. Participant's Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Product Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Norbrook Laboratories
      • 8.3.12.1. Participant's Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Product Benchmarking
      • 8.3.12.4. Strategic Initiatives
  • 8.4. Strategy Mapping
    • 8.4.1. Mergers & Acquisitions
    • 8.4.2. Partnerships & Collaborations
    • 8.4.3. Expansion
    • 8.4.4. Product launch
    • 8.4.5. Product Approval
    • 8.4.6. Others
  • 8.5. List of Key Companies
    • 8.5.1. List of Manufacturers
    • 8.5.2. List of Distributors

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Veterinary Antibiotics market, by region, 2018 - 2030 (USD Million)
  • Table 3 Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 4 Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 5 Veterinary Antibiotics market, by By Dosage Form, 2018 - 2030 (USD Million)
  • Table 6 North America Veterinary Antibiotics market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 8 North America Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 9 North America Veterinary Antibiotics market, by By Dosage Form, 2018 - 2030 (USD Million)
  • Table 10 U.S. Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 12 U.S. Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 13 Canada Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 14 Canada Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 15 Canada Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 16 Europe Veterinary Antibiotics market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 18 Europe Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 19 Europe Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 20 Germany Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 21 Germany Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 22 Germany Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 23 UK Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 24 UK Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 25 UK Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 26 France Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 27 France Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 28 France Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 29 Italy Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 30 Italy Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 31 Italy Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 32 Spain Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 33 Spain Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 34 Spain Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 35 Denmark Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 36 Denmark Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 37 Denmark Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 38 Sweden Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 39 Sweden Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 40 Sweden Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 41 Norway Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 42 Norway Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 43 Norway Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 44 Netherlands Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 45 Netherlands Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 46 Netherlands Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 47 Belgium Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 48 Belgium Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 49 Belgium Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 50 Portugal Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 51 Portugal Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 52 Portugal Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 53 Hungary Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 54 Hungary Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 55 Hungary Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 56 Poland Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 57 Poland Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 58 Poland Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 59 Romania Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 60 Romania Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 61 Romania Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Veterinary Antibiotics market, by country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 66 China Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 67 China Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 68 China Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 69 Japan Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 70 Japan Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 71 Japan Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 72 India Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 73 India Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 74 India Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 75 South Korea Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 76 South Korea Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 77 South Korea Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 78 Australia Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 79 Australia Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 80 Australia Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 81 Latin America Veterinary Antibiotics market, by country, 2018 - 2030 (USD Million)
  • Table 82 Latin America Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 83 Latin America Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 84 Latin America Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 85 Brazil Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 86 Brazil Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 87 Brazil Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 88 Mexico Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 89 Mexico Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 90 Mexico Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 91 Argentina Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 92 Argentina Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 93 Argentina Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 94 MEA Veterinary Antibiotics market, by country, 2018 - 2030 (USD Million)
  • Table 95 MEA Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 96 MEA Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 97 MEA Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 98 South Africa Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 99 South Africa Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 100 South Africa Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 101 Saudi Arabia Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 102 Saudi Arabia Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 103 Saudi Arabia Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 104 UAE Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 105 UAE Veterinary Antibiotics market, by Drug class, 2018 - 2030 (USD Million)
  • Table 106 UAE Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 107 Company Overview
  • Table 108 Product Benchmarking
  • Table 109 Financial Performance
  • Table 110 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Veterinary Antibiotics Market revenue, 2018 - 2030 (USD Million)
  • Fig. 10 Veterinary Antibiotics Market snapshot
  • Fig. 11 Veterinary Antibiotics Market driver impact
  • Fig. 12 Veterinary Antibiotics Market restraint impact
  • Fig. 13 Veterinary Antibiotics animal type key takeaways (USD Million)
  • Fig. 14 Veterinary Antibiotics market: animal Type movement analysis
  • Fig. 15 cattle market, 2018 - 2030 (USD Million)
  • Fig. 16 pigs market, 2018 - 2030 (USD Million)
  • Fig. 17 Sheep & Goat market, 2018 - 2030 (USD Million)
  • Fig. 18 poultry market, 2018 - 2030 (USD Million)
  • Fig. 19 others market, 2018 - 2030 (USD Million)
  • Fig. 20 Veterinary Antibiotics Market Drug class key takeaways (USD Million)
  • Fig. 21 Veterinary Antibiotics market: Drug class movement analysis
  • Fig. 22 Tetracyclines market, 2018 - 2030 (USD Million)
  • Fig. 23 Penicillins market, 2018 - 2030 (USD Million)
  • Fig. 24 Sulfonamides market, 2018 - 2030 (USD Million)
  • Fig. 25 Macrolides market, 2018 - 2030 (USD Million)
  • Fig. 26 Trimethoprim market, 2018 - 2030 (USD Million)
  • Fig. 27 Lincosamides market, 2018 - 2030 (USD Million)
  • Fig. 28 Polymyxins market, 2018 - 2030 (USD Million)
  • Fig. 29 Aminoglycosides market, 2018 - 2030 (USD Million)
  • Fig. 30 Fluoroquinolones market, 2018 - 2030 (USD Million)
  • Fig. 31 Pleuromutilins market, 2018 - 2030 (USD Million)
  • Fig. 32 Others market, 2018 - 2030 (USD Million)
  • Fig. 33 Veterinary Antibiotics Market by Dosage Form key takeaways (USD Million)
  • Fig. 34 Veterinary Antibiotics market: by Dosage Form movement analysis
  • Fig. 35 Oral powders market, 2018 - 2030 (USD Million)
  • Fig. 36 Oral Solutions, 2018 - 2030 (USD Million)
  • Fig. 37 Injections market, 2018 - 2030 (USD Million)
  • Fig. 38 Others market, 2018 - 2030 (USD Million)
  • Fig. 39 Regional market place: Key takeaways
  • Fig. 40 Regional outlook, 2023 & 2030
  • Fig. 41 North America Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 43 Canada Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 46 Germany Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 47 France Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 53 Netherlands companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 54 Belgium companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 55 Hungary companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 56 Poland companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 57 Portugal companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 58 Romania companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 60 Japan Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 61 China Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 62 India Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 63 Australia Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 67 Mexico Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 69 MEA Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 72 UAE Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 73 Market participant categorization